Although a report confirmed that elevated plasma VEGF levels are associated with an increased risk of dying from ccRCC, plasma VEGF levels are also significantly increased in tumors without VHL alteration. The gene discussed is VEGFA; the disease is nonpapillary renal cell carcinoma.